• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    KaloBios Pharmaceuticals, Inc. (KBIO)

    -NasdaqGM
    2.01 Up 0.04(2.03%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   44   6,098  
    Cost of Revenue -   -   -  
    Gross Profit -   44   6,098  
    Operating Expenses
    Research Development26,573  32,640  24,519  
    Selling General and Administrative10,145  8,313  5,061  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (36,718) (40,909) (23,482)
    Income from Continuing Operations
    Total Other Income/Expenses Net(66)47  157  
    Earnings Before Interest And Taxes(36,784)(40,862)(23,325)
    Interest Expense1,214  1,086  184  
    Income Before Tax(37,998)(41,948)(23,509)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(37,998)(41,948)(23,509)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (37,998) (41,948) (23,509)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (37,998) (41,948) (23,509)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.